Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LYEL

Lyell Immunopharma, Inc.

CIK 0001806952 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$15.21
↓ 0.19 (-1.23%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$354.91M
P/E Ratio
-1.44
EPS
-16.06
Dividend Yield
Not covered
52W Position
17%
Beta
1.90

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.30
P/S
Not covered
EV/Revenue
8,520.69
ROE
-90.0%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 17%
$9.03$45.00

Latest Financials

2025-12-31 FY
Revenue
$36.00K
Net Income
-$274.45M
Total Assets
$340.05M
Free Cash Flow
-$150.80M

Recent news